Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study
Bimekizumab治疗中重度斑块状银屑病:一项IIa期随机、双盲、多中心研究的疗效、安全性、药代动力学、药效学和转录组学分析
期刊:British Journal of Dermatology
影响因子:9.6
doi:10.1111/bjd.20827
Oliver, R; Krueger, J G; Glatt, S; Vajjah, P; Mistry, C; Page, M; Edwards, H; Garcet, S; Li, X; Dizier, B; Maroof, A; Watling, M; El Baghdady, A; Baeten, D; Ionescu, L; Shaw, S